# ALPS Medical Breakthroughs ETF

ALPS Medical Breakthroughs ETF is a ETF series of ALPS ETF TRUST (series S000047823). Net assets $161.8M as of 2026-05-31. Index fund.

## Profile

- Series ID: S000047823
- Registrant: ALPS ETF TRUST
- LEI: 549300UUE13R3N0UVB96
- Net assets: $161.8M
- Total assets: $161.9M
- As of: 2026-05-31
- Type: ETF, Index

## Advisers

- [ALPS Advisors, Inc. (Advisor)](https://search.stillhousedata.com/firm/134340)

## Top holdings (89 reported)

_Showing 15 of 89 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| [Alkermes Plc](https://search.stillhousedata.com/security/G01767105) | — | $7.2M | 447.80% |
| [Kymera Therapeutics Inc](https://search.stillhousedata.com/security/501575104) | — | $6.9M | 423.49% |
| [Celcuity Inc](https://search.stillhousedata.com/security/15102K100) | — | $6.3M | 391.70% |
| [Mirum Pharmaceuticals Inc](https://search.stillhousedata.com/security/604749101) | — | $6.3M | 390.20% |
| [Spyre Therapeutics Inc](https://search.stillhousedata.com/security/00773J202) | — | $6.0M | 367.78% |
| [Cg Oncology Inc](https://search.stillhousedata.com/security/156944100) | — | $5.4M | 335.07% |
| [Apogee Therapeutics Inc](https://search.stillhousedata.com/security/03770N101) | — | $4.7M | 293.05% |
| [Xenon Pharmaceuticals Inc](https://search.stillhousedata.com/security/98420N105) | — | $4.7M | 290.06% |
| [Travere Therapeutics Inc](https://search.stillhousedata.com/security/89422G107) | — | $4.5M | 277.18% |
| [Dianthus Therapeutics Inc](https://search.stillhousedata.com/security/252828108) | — | $4.3M | 263.52% |
| [Newamsterdam Pharma Co Nv](https://search.stillhousedata.com/security/N62509109) | — | $4.0M | 246.71% |
| [Viking Therapeutics Inc](https://search.stillhousedata.com/security/92686J106) | — | $3.9M | 241.02% |
| [Crinetics Pharmaceuticals Inc](https://search.stillhousedata.com/security/22663K107) | — | $3.8M | 237.07% |
| [Acadia Pharmaceuticals Inc](https://search.stillhousedata.com/security/004225108) | — | $3.8M | 235.27% |
| [Edgewise Therapeutics Inc](https://search.stillhousedata.com/security/28036F105) | — | $3.8M | 233.46% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-05-31 | $161.8M |
| 2026-02-28 | $138.0M |
| 2025-11-30 | $104.6M |
| 2025-08-31 | $81.0M |
| 2025-05-31 | $81.2M |
| 2025-02-28 | $94.1M |
| 2024-11-30 | $123.2M |
| 2024-08-31 | $114.1M |

## More

- [Registrant: ALPS ETF TRUST](https://search.stillhousedata.com/registrant/1414040)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000047823.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.